Matches in Wikidata for { <http://www.wikidata.org/entity/Q94352275> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q94352275 description "wetenschappelijk artikel" @default.
- Q94352275 description "наукова стаття" @default.
- Q94352275 name "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 name "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 type Item @default.
- Q94352275 label "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 label "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 prefLabel "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 prefLabel "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 P1433 Q94352275-A4498310-FA96-4BA1-BDAA-6A5BDB633B36 @default.
- Q94352275 P1476 Q94352275-BE2CE4D6-8E19-4CEF-8521-33A24C1CCE55 @default.
- Q94352275 P2093 Q94352275-046DE295-D15E-42F9-8E5F-550BE0E57446 @default.
- Q94352275 P2093 Q94352275-38A84E29-1E04-4AFE-99B9-FB8FB9394A93 @default.
- Q94352275 P2093 Q94352275-51865BDF-A9EC-4650-8707-83874FDE9EB2 @default.
- Q94352275 P2093 Q94352275-5973D5EC-E510-4358-B95E-443086174095 @default.
- Q94352275 P2093 Q94352275-81D0C69E-FEB9-4F3E-9DE2-D14050384E7A @default.
- Q94352275 P2093 Q94352275-A6BAFD29-CBA0-4D05-AA4E-E996FD60FE16 @default.
- Q94352275 P2093 Q94352275-B782A979-E3E7-4912-864A-BDBAE6F19C35 @default.
- Q94352275 P2093 Q94352275-E47C6923-7EDB-496B-8EE2-F506B6FA4BCF @default.
- Q94352275 P304 Q94352275-54FC5500-A095-4C6B-BD8D-EEC41D775EBB @default.
- Q94352275 P31 Q94352275-D0C9BFC0-E935-4A56-96E0-702679AEF04F @default.
- Q94352275 P356 Q94352275-90D39D59-73C0-4631-96FC-A8FAA7B5A1E3 @default.
- Q94352275 P433 Q94352275-AFBFA053-76B0-4D72-9D38-DA932922E2B5 @default.
- Q94352275 P478 Q94352275-978E76B9-CB17-4985-B9D9-3B2D7061761D @default.
- Q94352275 P50 Q94352275-629D8BD8-8494-46A1-80EF-0D764EDFEB1A @default.
- Q94352275 P50 Q94352275-C3CFC168-04EB-4004-9BC8-394D064B7018 @default.
- Q94352275 P577 Q94352275-0C46C965-CDA4-478A-988F-758EE57D596D @default.
- Q94352275 P921 Q94352275-5218B369-133F-4B30-93EC-5009DD291081 @default.
- Q94352275 P921 Q94352275-C3A47D6B-4219-4983-A071-8E6804527D9C @default.
- Q94352275 P921 Q94352275-E8126B34-6E0B-4A2A-B073-42B49691062E @default.
- Q94352275 P932 Q94352275-610C334C-5CD7-47DC-A11A-8CC33C95E317 @default.
- Q94352275 P356 NOU237.17 @default.
- Q94352275 P1433 Q15724471 @default.
- Q94352275 P1476 "AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA" @default.
- Q94352275 P2093 "Cedric Revil" @default.
- Q94352275 P2093 "Frank Saran" @default.
- Q94352275 P2093 "Martin J. van den Bent" @default.
- Q94352275 P2093 "Roger Henriksson" @default.
- Q94352275 P2093 "Ryo Nishikawa" @default.
- Q94352275 P2093 "Warren Mason" @default.
- Q94352275 P2093 "Wolfgang Wick" @default.
- Q94352275 P2093 "Yannick Kerloeguen" @default.
- Q94352275 P304 "v12-v12" @default.
- Q94352275 P31 Q13442814 @default.
- Q94352275 P356 "10.1093/NEUONC/NOU237.17" @default.
- Q94352275 P433 "Suppl 5" @default.
- Q94352275 P478 "16" @default.
- Q94352275 P50 Q47159504 @default.
- Q94352275 P50 Q56384070 @default.
- Q94352275 P577 "2014-11-01T00:00:00Z" @default.
- Q94352275 P921 Q282142 @default.
- Q94352275 P921 Q413299 @default.
- Q94352275 P921 Q425088 @default.
- Q94352275 P932 "4217794" @default.